Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clostridium difficile-associated disease: new challenges from an established pathogen.

Rebecca H Sunenshine1, L Clifford McDonald

  • 1Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, USA.

Cleveland Clinic Journal of Medicine
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of multidrug-resistant Gram-negative infections: a stewardship imperative.

The Lancet. Infectious diseases·2026
Same author

Uncovering the Hidden Impacts of Modern Medicine's Expanding Pharmacopeia on Clostridioides difficile Infection Risk.

The Journal of infectious diseases·2026
Same author

Projected impact of a pathogen reduction intervention on carbapenem-resistant Enterobacterales bloodstream infections and deaths in the United States.

Infection control and hospital epidemiology·2026
Same author

The Impact of a Nationwide Blood Culture Bottle Shortage in 2024 on Healthcare Facilities in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Changes in the Epidemiology of Clostridioides difficile Infection.

Infectious disease clinics of North America·2025
Same author

Estimated Burden of Coccidioidomycosis.

JAMA network open·2025

Clostridium difficile-associated disease (CDAD) is a growing concern, ranging from diarrhea to death. Increased rates may stem from a new C. difficile strain, with transmission occurring via healthcare worker and patient hands and contaminated environments.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Clostridium difficile-associated disease (CDAD) presents a spectrum of illness, from mild diarrhea to life-threatening sepsis.
  • Increasing incidence and severity of CDAD suggest potential emergence of novel virulent strains.
  • Healthcare settings are primary sites for C. difficile transmission.

Purpose of the Study:

  • To summarize the current understanding of Clostridium difficile-associated disease.
  • To highlight the increasing trends in CDAD incidence and severity.
  • To elucidate the primary transmission routes of C. difficile in healthcare environments.

Main Methods:

  • Literature review on Clostridium difficile epidemiology.
  • Analysis of trends in CDAD rates and clinical outcomes.

Related Experiment Videos

  • Review of established transmission pathways.

    • Main Results:

    • CDAD encompasses a range of clinical presentations, including severe outcomes like sepsis and mortality.
    • Observed increases in CDAD rates and severity are noted.
    • The fecal-oral route is the predominant transmission mechanism, involving contaminated hands of healthcare personnel and patients.
    • The patient care environment is a significant reservoir for C. difficile.

    Conclusions:

    • CDAD poses a significant and escalating threat in healthcare settings.
    • Emergence of new strains may contribute to increased disease severity.
    • Strict adherence to infection control protocols targeting hand hygiene and environmental decontamination is crucial to mitigate C. difficile transmission.